{"id":"W2146308079","doi":"10.1007/s11060-015-1894-y","title":"A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas","year":2015,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"ca_institutions":"Columbia College","funders":"National Institutes of Health","keywords":"Medicine; Bortezomib; Internal medicine; Glioma; Phases of clinical research; Tamoxifen; Oncology; Gastroenterology; Toxicity; Surgery; Cancer; Multiple myeloma; Breast cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001236056,0.001245233,0.002563187,0.0004293403,0.0003950587,0.0008866974,0.0007781379,0.001307189,0.003387807],"category_scores_gemma":[0.001153786,0.0005251767,0.001430735,0.0004851667,0.0009955624,0.0009761303,0.0003645369,0.003044011,0.0008577634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009298261,"about_ca_system_score_gemma":0.001156649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001546795,"about_ca_topic_score_gemma":0.004707874,"domain_scores_codex":[0.9995955,0.000182401,0.00002564418,0.00007145025,0.00002564068,0.00009940796],"domain_scores_gemma":[0.999369,0.0001427993,0.0001076697,0.00005255161,0.00002875356,0.00029931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8778556,0.01291115,0.00438294,0.0007619718,0.001881648,0.0002391694,0.0003110707,0.001513616,0.01704193,0.000215128,0.00274231,0.0801435],"study_design_scores_gemma":[0.7625676,0.2231222,0.007892667,0.00004774583,0.0009516752,0.0003624134,0.0001490792,0.0006482528,0.001342763,0.0002019924,0.002683741,0.00002996681],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933043,0.003656693,0.0001747404,0.0008159064,0.000174867,0.0004246361,0.0003585301,0.00004867996,0.001041514],"genre_scores_gemma":[0.9921302,0.002938243,0.0005585169,0.0007838891,0.0001873869,0.0006208949,0.00111491,0.00002351303,0.001642447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003387807,"threshold_uncertainty_score":0.01133335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03661502940811316,"score_gpt":0.3307358211320278,"score_spread":0.2941207917239146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}